We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Light-Induced Immunoassay Selectively Detects Coronavirus Spike Proteins In 5 Minutes

By LabMedica International staff writers
Posted on 19 Sep 2024

Like moths drawn to a flame, microbes can also be influenced by light. More...

Using this principle, researchers have developed a method to quickly detect viruses using only a small sample.

Scientists at Osaka Metropolitan University's Research Institute for Light-induced Acceleration System (RILACS) have developed a light-induced immunoassay for virus detection. By applying laser irradiation for less than a minute, they used a nanoparticle-imprinted plasmonic substrate with nanobowl structures (each 500 nm in diameter) coated with antibodies for the spike proteins of the novel coronavirus. A low-power 5-milliwatt laser, similar to commercial laser pointers, was able to form bubbles on the biochip that attracted virus-mimicking nanoparticles, speeding up the selective detection of these particles.

The process works because light-induced convection causes the nanoparticles to move and gather at a stagnant region between the substrate surface and the bottom of the bubble, meaning a high particle concentration isn't necessary. The entire procedure—from coating the substrate to detecting the virus—can be completed in under 5 minutes, as reported in the journal npj Biosensing.

“This study shows that we can shorten the cumbersome antibody coating process and perform rapid and highly sensitive protein detection,” said OMU Professor Takuya Iida, the director of RILACS. “We believe our findings can contribute to the early diagnosis of not only the novel coronavirus, but possibly also various infectious diseases, cancer, even dementia.”

Related Links:
RILACS


Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Homocysteine Quality Control
Liquichek Homocysteine Control
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Industry

view channel
Image: The LIAISON NES molecular point-of-care platform (Photo courtesy of Diasorin)

Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform

Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.